Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease
2018 · Neuron · 502 citations
https://doi.org/10.1016/j.neuron.2018.10.031
Q
Qian Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
373
Papers
11.1K
Citations
48
h-index
170
i10-index
Qian Wang is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Neuroinflammation and Neurodegeneration Mechanisms & Alzheimer's disease research and treatments & Tryptophan and brain disorders. The author has an h-index of 48, co-authored 318 publications.
ORCID: 0000-0001-5504-0008Papers by this author
worksRestoring metabolism of myeloid cells reverses cognitive decline in ageing
2021 · Nature · 486 citations
https://doi.org/10.1038/s41586-020-03160-0
Molecular subtyping of Alzheimer’s disease using RNA sequencing data reveals novel mechanisms and targets
2021 · Science Advances · 317 citations
https://doi.org/10.1126/sciadv.abb5398
The landscape of multiscale transcriptomic networks and key regulators in Parkinson’s disease
2019 · Nature Communications · 146 citations
https://doi.org/10.1038/s41467-019-13144-y
CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys
2021 · Cell Death and Disease · 137 citations
https://doi.org/10.1038/s41419-021-03813-6
Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice
2016 · Brain · 105 citations
https://doi.org/10.1093/brain/aww117
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat